NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.

美国国立卫生研究院国家过敏和传染病研究所(NIAID)的戴尔和贝蒂·邦珀斯疫苗研究中心(VRC)的成立是为了促进疫苗开发的研究，致力于通过严格追求有效的人类疾病疫苗和治疗来改善全球人类健康。VRC使命的关键组成部分之一涉及将有前途的候选人从实验室迅速提升到临床。要实现这一使命，就必须开发和制造毒理学疫苗，以及1/11期临床试验。

The Dale and Betty Bumpers Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), at the National Institutes of Health, was established to facilitate research in vaccine development and is dedicated to improving global human health through the rigorous pursuit of effective vaccines and treatments for human diseases. One of the key components of the VRC's mission involves the rapid advancement of promising candidates from the laboratory to the clinic. Meeting this mission necessitates the development and manufacturing of vaccines for toxicology, and Phase 1/11 clinical trials.